WVE
Wave Life Sciences Ltd
4.00$
+0.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -70.0% | -114.4% | -266.6% | -139.5% | – | -52.1% | -687.1% | -528.9% | -587.1% | -186.3% | -155.7% | -2,127.5% | -282.5% | |
| 4.6% | 7.5% | 17.4% | 11.0% | – | 2.6% | 23.6% | 25.2% | 29.3% | 13.1% | 3.8% | 66.5% | 11.4% | |
| 4.6% | 8.1% | 23.0% | 17.7% | – | 3.9% | 54.0% | 71.2% | 85.1% | -102.2% | 23.7% | 472.4% | 13.2% | |
| -94.0% | -73.6% | -55.3% | -1.0% | – | -93.5% | -253.7% | -45.2% | 6.4% | 59.2% | -117.2% | 2,204.2% | 24.4% | |
| 0.4% | 1.2% | 3.3% | 0.3% | – | 0.1% | 1.8% | 3.5% | 3.3% | 0.1% | 1.1% | 38.9% | 2.4% | |
| -0.4% | -1.2% | -3.3% | -0.3% | – | -0.1% | -1.8% | -3.5% | -3.3% | 0.1% | -1.1% | -5,433.7% | -189.9% | |
| 3.4% | 323.4% | 115.7% | 3.3% | – | 41.8% | 45.3% | 134.4% | 429.7% | 2,566.7% | 6.6% | -96.7% | 727.6% | |
| -67.1% | 208.0% | -154.8% | -136.8% | – | -10.6% | -643.0% | -397.5% | -161.0% | 2,353.4% | -150.3% | -7,652.5% | 248.2% | |
| -70.4% | -115.6% | -270.0% | -139.8% | – | -52.2% | -688.9% | -532.5% | -590.4% | -186.2% | -156.9% | -2,166.4% | -284.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.